Credit: Merck Enflonsia is an extended half-life RSV fusion glycoprotein neutralizing monoclonal antibody. The product is administered as a single intramuscular injection using the same dose ...
Respiratory Syncytial Virus is increasing in Northeast Florida, according to the Florida Department of Health.
Clesrovimab is a long-acting investigational monoclonal antibody against site IV of the respiratory syncytial virus (RSV) fusion protein. Data regarding the safety and efficacy of clesrovimab in ...
CAMBRIDGE, MA / ACCESS Newswire / June 12, 2025 / Moderna, Inc. (MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA® (mRNA-1345), the Company's respiratory ...
Guidelines recommend a single dose of RSV vaccine for older adults, but long-term data on the duration of protection is limited. In this study of U.S. veterans, effectiveness slid from over 80% in the ...
There have been 3,191 reported flu cases and 456 reported RSV cases in San Diego during the 2025 – 2026 season, according to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback